Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?

Ribaldone, D G

Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? [electronic resource] - Alimentary pharmacology & therapeutics 01 2018 - 146-147 p. digital

Publication Type: Letter; Comment

1365-2036

10.1111/apt.14321 doi


Biological Products
Crohn Disease
Digestive System Surgical Procedures
Humans
Infliximab
Tumor Necrosis Factor-alpha